REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 122 filers reported holding REVANCE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $830,000 | -23.3% | 72,263 | +69.2% | 0.00% | – |
| Q2 2023 | $1,082,000 | -23.3% | 42,710 | -2.5% | 0.00% | – |
| Q1 2023 | $1,411,000 | +20.0% | 43,813 | -31.2% | 0.00% | – |
| Q4 2022 | $1,176,000 | -16.8% | 63,692 | +21.6% | 0.00% | – |
| Q3 2022 | $1,414,000 | +39.4% | 52,372 | -28.7% | 0.00% | – |
| Q2 2022 | $1,014,000 | -7.9% | 73,437 | +30.1% | 0.00% | – |
| Q1 2022 | $1,101,000 | +18.6% | 56,464 | -0.7% | 0.00% | – |
| Q4 2021 | $928,000 | -19.9% | 56,865 | +36.7% | 0.00% | – |
| Q3 2021 | $1,158,000 | +58.6% | 41,584 | +69.0% | 0.00% | – |
| Q2 2021 | $730,000 | -11.4% | 24,613 | -16.6% | 0.00% | – |
| Q1 2021 | $824,000 | -25.7% | 29,525 | -24.6% | 0.00% | – |
| Q4 2020 | $1,109,000 | +74.4% | 39,144 | +54.7% | 0.00% | – |
| Q3 2020 | $636,000 | +7.4% | 25,302 | +4.5% | 0.00% | – |
| Q2 2020 | $592,000 | +65.4% | 24,222 | +0.2% | 0.00% | – |
| Q1 2020 | $358,000 | -9.4% | 24,180 | -0.8% | 0.00% | – |
| Q4 2019 | $395,000 | -2.2% | 24,387 | -21.4% | 0.00% | – |
| Q3 2019 | $404,000 | -1.9% | 31,045 | -2.4% | 0.00% | – |
| Q2 2019 | $412,000 | -2.4% | 31,798 | +19.0% | 0.00% | – |
| Q1 2019 | $422,000 | -13.5% | 26,730 | +10.3% | 0.00% | – |
| Q4 2018 | $488,000 | -23.8% | 24,229 | -5.9% | 0.00% | – |
| Q3 2018 | $640,000 | -9.1% | 25,759 | +0.5% | 0.00% | – |
| Q2 2018 | $704,000 | -13.7% | 25,629 | -3.3% | 0.00% | – |
| Q1 2018 | $816,000 | -10.9% | 26,496 | +3.4% | 0.00% | – |
| Q4 2017 | $916,000 | +21.6% | 25,622 | -6.2% | 0.00% | – |
| Q3 2017 | $753,000 | +20.1% | 27,321 | +14.9% | 0.00% | – |
| Q2 2017 | $627,000 | +49.6% | 23,768 | +18.1% | 0.00% | – |
| Q1 2017 | $419,000 | -2.3% | 20,131 | -2.9% | 0.00% | – |
| Q4 2016 | $429,000 | +35.3% | 20,740 | +6.2% | 0.00% | – |
| Q3 2016 | $317,000 | +21.5% | 19,535 | +1.6% | 0.00% | – |
| Q2 2016 | $261,000 | -26.1% | 19,228 | -4.9% | 0.00% | – |
| Q1 2016 | $353,000 | +65.0% | 20,220 | +221.6% | 0.00% | – |
| Q4 2015 | $214,000 | +422.0% | 6,287 | +352.3% | 0.00% | – |
| Q3 2015 | $41,000 | -28.1% | 1,390 | -21.2% | 0.00% | – |
| Q2 2015 | $57,000 | +338.5% | 1,765 | +171.5% | 0.00% | – |
| Q1 2015 | $13,000 | -13.3% | 650 | -27.9% | 0.00% | – |
| Q4 2014 | $15,000 | +15.4% | 901 | +38.6% | 0.00% | – |
| Q3 2014 | $13,000 | -98.5% | 650 | -97.5% | 0.00% | -100.0% |
| Q2 2014 | $888,000 | +151.6% | 26,125 | +133.3% | 0.00% | – |
| Q1 2014 | $353,000 | – | 11,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
| Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
| Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
| Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
| Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
| Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
| Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
| TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |